科兴制药涨2.03%，成交额8791.64万元，主力资金净流入198.92万元

Core Viewpoint - The stock price of Kexing Pharmaceutical has shown significant volatility, with a year-to-date increase of 94.21% and recent fluctuations in trading performance [2] Group 1: Stock Performance - As of September 18, Kexing Pharmaceutical's stock rose by 2.03%, reaching 42.30 CNY per share, with a total market capitalization of 8.513 billion CNY [1] - The stock has experienced a 3.50% increase over the last five trading days, a 2.98% decrease over the last 20 days, and a 9.47% increase over the last 60 days [2] Group 2: Financial Performance - For the first half of 2025, Kexing Pharmaceutical reported a revenue of 700 million CNY, a year-on-year decrease of 7.82%, while the net profit attributable to shareholders was 80.3445 million CNY, reflecting a substantial year-on-year increase of 576.45% [2] - Cumulatively, the company has distributed 51.5446 million CNY in dividends since its A-share listing, with 15.7785 million CNY distributed over the past three years [3] Group 3: Shareholder Information - As of June 30, 2025, the number of shareholders increased by 16.86% to 9,412, while the average circulating shares per person decreased by 14.43% to 21,211 shares [2] - The top shareholders include various mutual funds, with notable increases in holdings from E Fund Medical Healthcare Industry Mixed A and other funds [3]